Novartis (NVS) provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, cost-saving generic and biosimilar pharmaceuticals and eye care. Novartis has leading positions globally in each of these areas. Novartis Group companies employ approximately 122,000 full-time-equivalent associates. Novartis products are sold in approximately 155 countries around the world. The company has been honoured and received numerous awards for progress in research and development, their working environment, and their corporate responsibility activities. Novartis shares are listed and traded on the SIX Swiss Exchange (symbol “NOVN”) as well as on the New York Stock Exchange in the form of ADR (symbol “NVS”). Get all the latest on Novartis Repsg (NVS) share price at Capital.com. Markets swing as traders re-adjust to trading in Trump’s worldExplore market reactions to Trump's trade policies, including USD drops, oil price shifts, and tariff impacts.
08:15, 21 January 2025
USD/JPY drops below 156 as US CPI eases and BOJ rate hike expectations increaseAn increase in rate hike expectations from the BOJ and softer US CPI data see USD/JPY turn lower
14:47, 16 January 2025
UK inflation cools in December, GBP/USD attempts to bounce backUK inflation drops more than expected in December, easing some of the fears about the UK economy.
09:41, 15 January 2025
Market Analysis: EUR/GBP Extends Rally but Faces Key ResistanceA worsening economic outlook in the UK is driving the pound lower, pushing EUR/GBP to a two-and-a-half-month high.
14:56, 14 January 2025